S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
All the trading advice you’ve ever received boils down to this (Ad)
Hong Kong court puts off Chinese developer Evergrande's hearing on its debt restructuring to January
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
All the trading advice you’ve ever received boils down to this (Ad)
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
All the trading advice you’ve ever received boils down to this (Ad)
Hong Kong court puts off Chinese developer Evergrande's hearing on its debt restructuring to January
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
All the trading advice you’ve ever received boils down to this (Ad)
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
All the trading advice you’ve ever received boils down to this (Ad)
Hong Kong court puts off Chinese developer Evergrande's hearing on its debt restructuring to January
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
All the trading advice you’ve ever received boils down to this (Ad)
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
All the trading advice you’ve ever received boils down to this (Ad)
Hong Kong court puts off Chinese developer Evergrande's hearing on its debt restructuring to January
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
All the trading advice you’ve ever received boils down to this (Ad)
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt

Bioceres Crop Solutions Stock Price, News & Analysis (NASDAQ:BIOX)

$12.36
+0.16 (+1.31%)
(As of 12/1/2023 ET)
Compare
Today's Range
$12.04
$12.39
50-Day Range
$10.33
$12.36
52-Week Range
$9.76
$14.20
Volume
205,379 shs
Average Volume
95,483 shs
Market Capitalization
$776.21 million
P/E Ratio
68.67
Dividend Yield
N/A
Price Target
$20.00

Bioceres Crop Solutions MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
61.8% Upside
$20.00 Price Target
Short Interest
Bearish
1.04% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.44mentions of Bioceres Crop Solutions in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
46.58%
From $0.73 to $1.07 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.28 out of 5 stars

Consumer Staples Sector

54th out of 118 stocks

Agricultural Chemicals Industry

4th out of 9 stocks


BIOX stock logo

About Bioceres Crop Solutions Stock (NASDAQ:BIOX)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

BIOX Stock Price History

BIOX Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Earnings Outlook For Bioceres Crop Solutions
Bioceres Crop Solutions Corp BIOX
Bioceres Crop Solutions Corp. (KYG1117K1141.SG)
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Bioceres Crop Solutions' HB4 Technology: A Game Changer
See More Headlines
Receive BIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioceres Crop Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/11/2023
Today
12/03/2023
Next Earnings (Estimated)
2/14/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Agricultural chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOX
Fax
N/A
Employees
447
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.00
High Stock Price Target
$25.00
Low Stock Price Target
$15.00
Potential Upside/Downside
+61.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$18.78 million
Pretax Margin
1.94%

Debt

Sales & Book Value

Annual Sales
$419.80 million
Cash Flow
$0.57 per share
Book Value
$5.30 per share

Miscellaneous

Free Float
61,346,000
Market Cap
$776.21 million
Optionable
Not Optionable
Beta
0.48
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Jose A. Roque
    General Counsel
  • Alex Garcia
    Managing Director of Seeds
  • Dr. Federico Trucco Ph.D. (Age 46)
    Chairman & CEO
    Comp: $131.16k
  • Mr. Enrique López Lecube (Age 41)
    CFO & Executive Director
    Comp: $129.89k
  • Mr. Jorge Wagner (Age 54)
    Chief Operating Officer
    Comp: $165.6k
  • Ms. Paula Savanti
    Head of Investor Relations
  • Mr. Ricardo Luis Yapur (Age 65)
    Managing Director of Latam Unit & Chief Commercial Officer
    Comp: $260k
  • Mr. Matti Tiainen (Age 33)
    Managing Director of North America & Europe














BIOX Stock Analysis - Frequently Asked Questions

Should I buy or sell Bioceres Crop Solutions stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bioceres Crop Solutions in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BIOX shares.
View BIOX analyst ratings
or view top-rated stocks.

What is Bioceres Crop Solutions' stock price target for 2024?

3 brokerages have issued 1-year price targets for Bioceres Crop Solutions' stock. Their BIOX share price targets range from $15.00 to $25.00. On average, they expect the company's stock price to reach $20.00 in the next twelve months. This suggests a possible upside of 61.8% from the stock's current price.
View analysts price targets for BIOX
or view top-rated stocks among Wall Street analysts.

How have BIOX shares performed in 2023?

Bioceres Crop Solutions' stock was trading at $12.03 at the beginning of the year. Since then, BIOX shares have increased by 2.7% and is now trading at $12.36.
View the best growth stocks for 2023 here
.

Are investors shorting Bioceres Crop Solutions?

Bioceres Crop Solutions saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 311,100 shares, an increase of 20.6% from the October 31st total of 257,900 shares. Based on an average daily volume of 65,700 shares, the short-interest ratio is presently 4.7 days. Currently, 1.0% of the company's shares are sold short.
View Bioceres Crop Solutions' Short Interest
.

When is Bioceres Crop Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 14th 2024.
View our BIOX earnings forecast
.

How were Bioceres Crop Solutions' earnings last quarter?

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) posted its earnings results on Monday, September, 11th. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of $0.04 by $0.10. The business earned $104.70 million during the quarter, compared to analysts' expectations of $96.59 million. Bioceres Crop Solutions had a net margin of 2.71% and a trailing twelve-month return on equity of 3.40%. During the same quarter in the previous year, the company posted ($0.12) earnings per share.

What other stocks do shareholders of Bioceres Crop Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bioceres Crop Solutions investors own include Arcadia Biosciences (RKDA), ChromaDex (CDXC), Trevena (TRVN), Advanced Micro Devices (AMD), Amyris (AMRS), Celldex Therapeutics (CLDX), Chimerix (CMRX), CTI BioPharma (CTIC).

When did Bioceres Crop Solutions IPO?

(BIOX) raised $130 million in an initial public offering (IPO) on Wednesday, February 7th 2018. The company issued 11,800,000 shares at a price of $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey served as the underwriters for the IPO and Mirabaud Securities was co-manager.

Who are Bioceres Crop Solutions' major shareholders?

Bioceres Crop Solutions' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Ballast Asset Management LP (0.31%), Polar Capital Holdings Plc (0.30%), Federated Hermes Inc. (0.22%), Albert D Mason Inc. (0.11%), Oak Family Advisors LLC (0.10%) and Toroso Investments LLC (0.09%).

How do I buy shares of Bioceres Crop Solutions?

Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:BIOX) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -